CLINICAL_TRIALS
trial_result
· 2023-08-14
Clinical Trial Update: Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration [Phase 2]
Summary
Phase 2 clinical trial updating safety, tolerability, and efficacy of aflibercept for neovascular age-related macular degeneration has completed with posted res…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Neovascular (Wet) Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14